<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03315234</url>
  </required_header>
  <id_info>
    <org_study_id>CIP_PhD Rampidis Georgios_1.1</org_study_id>
    <nct_id>NCT03315234</nct_id>
  </id_info>
  <brief_title>Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease</brief_title>
  <official_title>Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease in the Greek Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LABNET IAE - Private Reference Diagnostic Laboratory</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the research project is to investigate the potential association of 6 genetic
      polymorphisms with the complexity and the severity of coronary artery disease (SYNTAX score).
      The aim of the study is to combine genetic, clinical and laboratory data in order to create a
      prognostic tool that will enable an individualized therapeutic patient approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study focus on the prediction of future risk of cardiovascular events, assessing the
      severity and complexity of coronary artery disease by incorporating genetic information into
      the SYNTAX score and providing personalized therapeutic guidance to patients. The ultimate
      goal of the study would be to identify, design and develop a panel of genetic markers that in
      combination with clinical and angiographic information will be a reliable tool for predicting
      cardiovascular risk for future adverse events. Clinical and genetic patient information are
      systematically collected in a fashion that will enable also retrospective evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Relationship between genetic risk variants and the SYNTAX score [All-comers population]</measure>
    <time_frame>12 months</time_frame>
    <description>The investigators will evaluate the effects of 6 known genetic variants associated with risk of Coronary Artery Disease on the extend and severity of coronary atherosclerosis [as assessed by the SYNTAX score] in patients with significant CAD on coronary angiography, both individually and combined in a Genetic Risk Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACCEs</measure>
    <time_frame>12 months</time_frame>
    <description>Cardiovascular death, myocardial infarction, stent thrombosis, any re-intervention and stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of combining a Genetic Risk Score &amp; SYNTAX score for the prediction of 1-year MACCEs</measure>
    <time_frame>12 months</time_frame>
    <description>A Genetic Risk Score will be calculated as the weighted sum of alleles of 6 single nucleotide polymorphisms previously associated with CAD [The GRS will be constructed by summing the number of risk alleles (0/1/2) for each of the 6 SNPs weighted by their estimated effect sizes].
SYNTAX score is a coronary lesion complexity scoring system and represented by a single number.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankle-Brachial Index</measure>
    <time_frame>At hospital admission</time_frame>
    <description>A tool for diagnosing peripheral artery disease but also an indicator of systemic atherosclerosis [represented by a single number]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction</measure>
    <time_frame>At hospital admission &amp; 12 months after discharge from hospital</time_frame>
    <description>LVEF [%] as assessed by echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil to Lymphocyte Ratio</measure>
    <time_frame>At hospital admission</time_frame>
    <description>NLR [represented by a single number]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Red Cell Distribution Width</measure>
    <time_frame>At hospital admission</time_frame>
    <description>RDW [%]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Platelet Volume</measure>
    <time_frame>At hospital admission</time_frame>
    <description>MPV [fL]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glomerular Filtration Rate</measure>
    <time_frame>At hospital admission</time_frame>
    <description>GFR as assessed by CKD-EPI formula [mL/min/1.73m²]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoprotein</measure>
    <time_frame>At hospital admission</time_frame>
    <description>HDL [mg/dL]</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Coronary Arteriosclerosis</condition>
  <arm_group>
    <arm_group_label>SYNTAX score = 0</arm_group_label>
    <description>Patients with nonobstructive CAD (≤50 % diameter stenosis)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0 &lt; SYNTAX score &lt; 23</arm_group_label>
    <description>Low SYNTAX group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SYNTAX score ≥ 23</arm_group_label>
    <description>Intermediate-High SYNTAX group</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>SNPs associated with CAD</intervention_name>
    <description>Genotyping will be carried out by Real-Time PCR</description>
    <arm_group_label>SYNTAX score = 0</arm_group_label>
    <arm_group_label>0 &lt; SYNTAX score &lt; 23</arm_group_label>
    <arm_group_label>SYNTAX score ≥ 23</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA will be extracted from obtained subject blood samples at the AHEPA University General
      Hospital of Thessaloniki. DNAs will be labeled by anonymized subject ID # (de-identified),
      and shipped to LABNET IAE - Private Reference Diagnostic Laboratory for genotyping and
      genetic analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients between 18 years to 90 years at entry, of both genders, who are admitted in the
        Department of Cardiology in the AHEPA University General Hospital of Thessaloniki and
        undergo coronary angiography for clinical purposes will be studied
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who are admitted in the Department of Cardiology in the AHEPA University
             General Hospital of Thessaloniki and undergo coronary angiography for clinical
             purposes

          2. Patients giving voluntary written consent to participate in the study

          3. Male or female patients between 18 years to 90 years at entry

          4. Patients without previous history of CAD

        Exclusion Criteria:

          1. Patients &lt; 18 years old and &gt; 90 years old at time of coronary angiography

          2. Patients with a previous history of CAD

          3. Cardiac Arrest at admission

          4. Patients with serious concurrent disease and life expectancy of &lt; 1 year

          5. Patients who refuse to give written consent for participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgios Rampidis, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>AHEPA University Hospital, 1st Cardiology Department - PhD candidate</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgios Sianos, MD, PhD, FESC</last_name>
    <role>Principal Investigator</role>
    <affiliation>AHEPA University Hospital, 1st Cardiology Department - PhD Supervisor 1</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charalambos Karvounis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AHEPA University Hospital, 1st Cardiology Department, Director - PhD Supervisor 2</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ioannis Vizirianakis, PharmD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aristotle University of Thessaloniki, School of Pharmacy - PhD Supervisor 3</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georgios Rampidis, MD, MSc</last_name>
    <phone>+306976254340</phone>
    <email>grampidi@auth.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AHEPA University Hospital</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgios Rampidis, MD, MSc</last_name>
      <phone>+306976254340</phone>
      <email>grampidi@auth.gr</email>
    </contact>
    <investigator>
      <last_name>Georgios Rampidis, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 Aug;1(2):219-27.</citation>
    <PMID>19758907</PMID>
  </reference>
  <reference>
    <citation>Knowles JW, Zarafshar S, Pavlovic A, Goldstein BA, Tsai S, Li J, McConnell MV, Absher D, Ashley EA, Kiernan M, Ioannidis JPA, Assimes TL. Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study. Front Cardiovasc Med. 2017 Aug 14;4:53. doi: 10.3389/fcvm.2017.00053. eCollection 2017.</citation>
    <PMID>28856136</PMID>
  </reference>
  <reference>
    <citation>Howson JMM, Zhao W, Barnes DR, Ho WK, Young R, Paul DS, Waite LL, Freitag DF, Fauman EB, Salfati EL, Sun BB, Eicher JD, Johnson AD, Sheu WHH, Nielsen SF, Lin WY, Surendran P, Malarstig A, Wilk JB, Tybjærg-Hansen A, Rasmussen KL, Kamstrup PR, Deloukas P, Erdmann J, Kathiresan S, Samani NJ, Schunkert H, Watkins H; CARDIoGRAMplusC4D, Do R, Rader DJ, Johnson JA, Hazen SL, Quyyumi AA, Spertus JA, Pepine CJ, Franceschini N, Justice A, Reiner AP, Buyske S, Hindorff LA, Carty CL, North KE, Kooperberg C, Boerwinkle E, Young K, Graff M, Peters U, Absher D, Hsiung CA, Lee WJ, Taylor KD, Chen YH, Lee IT, Guo X, Chung RH, Hung YJ, Rotter JI, Juang JJ, Quertermous T, Wang TD, Rasheed A, Frossard P, Alam DS, Majumder AAS, Di Angelantonio E, Chowdhury R; EPIC-CVD, Chen YI, Nordestgaard BG, Assimes TL, Danesh J, Butterworth AS, Saleheen D. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. Nat Genet. 2017 Jul;49(7):1113-1119. doi: 10.1038/ng.3874. Epub 2017 May 22.</citation>
    <PMID>28530674</PMID>
  </reference>
  <reference>
    <citation>Assimes TL, Roberts R. Genetics: Implications for Prevention and Management of Coronary Artery Disease. J Am Coll Cardiol. 2016 Dec 27;68(25):2797-2818. doi: 10.1016/j.jacc.2016.10.039. Review.</citation>
    <PMID>28007143</PMID>
  </reference>
  <reference>
    <citation>Vizirianakis IS, Fatouros DG. Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements. Adv Drug Deliv Rev. 2012 Oct;64(13):1359-62. doi: 10.1016/j.addr.2012.09.034. Epub 2012 Sep 13.</citation>
    <PMID>22983333</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2017</study_first_submitted>
  <study_first_submitted_qc>October 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Georgios Rampidis</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>SYNTAX score</keyword>
  <keyword>Coronary Atherosclerosis</keyword>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>SNPs</keyword>
  <keyword>Genetics</keyword>
  <keyword>Genetic Risk Score</keyword>
  <keyword>Personalized Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

